Immunis.AI to Present at the BIO CEO & Investor ConferenceJoel Wolter2020-02-06T20:07:34-05:00February 6, 2020|Read More
A OncoCell MDx, Now Immunis.AI, to Present at Biotech ShowcaseJoel Wolter2020-01-10T12:28:57-05:00January 10, 2020|Read More
A Message From the President and CEO – Six Months of Growthkari.sharp@gmail.com2020-01-08T18:38:43-05:00October 30, 2019|Read More
OncoCell MDx, Inc. Raises $22.2 Million in Series B Financingkari.sharp@gmail.com2020-01-08T18:48:05-05:00September 11, 2019|Read More
A Message from the President and CEOkari.sharp@gmail.com2020-01-08T18:39:50-05:00August 1, 2019|Read More
OncoCell MDx Appoints Renowned Urologic Pathologist as Chief Medical Officerkari.sharp@gmail.com2020-01-08T18:47:25-05:00July 18, 2019|Read More
OncoCell MDx Prepares for Commercialization with Appointment of Christopher Thibodeau as Chief Operating Officerkari.sharp@gmail.com2020-01-08T18:49:38-05:00July 9, 2019|Read More
OncoCell MDx Announces Mark McDonough as New President & Chief Executive Officerkari.sharp@gmail.com2020-01-05T19:15:06-05:00April 30, 2019|Read More
